经皮冠状动脉介入治疗-话题@MedSci

#经皮冠状动脉介入治疗#

52篇内容 | 2675人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1320748, encodeId=2c271320e487d, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Lancet：冠状动脉旁路移植术与经皮冠状动脉介入治疗对不同类型冠心病患者死亡率的影响, objectType=article, longId=130347, objectId=434f13034e23, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434f13034e23, replyNumber=0, likeNumber=64, createdTime=2018-02-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434f13034e23, moduleTitle=Lancet：冠状动脉旁路移植术与经皮冠状动脉介入治疗对不同类型冠心病患者死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=434f13034e23)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320747, encodeId=0b481320e47c0, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Circ-Cardiovasc Inte：经皮冠状动脉介入治疗后腹膜后出血！, objectType=article, longId=130012, objectId=525013001207, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=525013001207, replyNumber=0, likeNumber=57, createdTime=2018-02-16, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=525013001207, moduleTitle=Circ-Cardiovasc Inte：经皮冠状动脉介入治疗后腹膜后出血！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=525013001207)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320746, encodeId=290c1320e4619, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Circ-Cardiovasc Inte：经皮冠状动脉介入治疗的终末期肾病患者抗凝治疗！, objectType=article, longId=129192, objectId=153312919251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=153312919251, replyNumber=0, likeNumber=65, createdTime=2018-02-09, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=153312919251, moduleTitle=Circ-Cardiovasc Inte：经皮冠状动脉介入治疗的终末期肾病患者抗凝治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=153312919251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320745, encodeId=b4341320e4559, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Heart：不同抗血小板治疗与经皮冠状动脉介入治疗死亡率之间的关系！, objectType=article, longId=128759, objectId=bcda128e592a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcda128e592a, replyNumber=0, likeNumber=76, createdTime=2018-02-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcda128e592a, moduleTitle=Heart：不同抗血小板治疗与经皮冠状动脉介入治疗死亡率之间的关系！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcda128e592a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320744, encodeId=40b61320e4446, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=HEART：慢性完全闭塞经皮冠状动脉介入治疗的预测因素！, objectType=article, longId=116212, objectId=9ce3116212e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce3116212e7, replyNumber=0, likeNumber=83, createdTime=2017-10-16, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce3116212e7, moduleTitle=HEART：慢性完全闭塞经皮冠状动脉介入治疗的预测因素！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce3116212e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320743, encodeId=f97a1320e433a, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Diabetic Med：糖尿病对慢性全身闭塞经皮冠状动脉介入治疗急性结局的影响, objectType=article, longId=104776, objectId=2c98104e76f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c98104e76f5, replyNumber=0, likeNumber=70, createdTime=2017-07-08, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c98104e76f5, moduleTitle=Diabetic Med：糖尿病对慢性全身闭塞经皮冠状动脉介入治疗急性结局的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c98104e76f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320742, encodeId=e0c91320e42fb, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=CIRC J：血清白蛋白和C反应蛋白对经皮冠状动脉介入治疗患者的远期结局的作用, objectType=article, longId=97222, objectId=faa19e222c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faa19e222c9, replyNumber=0, likeNumber=91, createdTime=2017-04-28, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faa19e222c9, moduleTitle=CIRC J：血清白蛋白和C反应蛋白对经皮冠状动脉介入治疗患者的远期结局的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faa19e222c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320741, encodeId=47c51320e4105, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JAHA：左心室肥厚与接受经皮冠状动脉介入治疗的STEMI患者的梗死面积增大有关！, objectType=article, longId=87242, objectId=e01a8e24227, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e01a8e24227, replyNumber=0, likeNumber=86, createdTime=2017-01-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e01a8e24227, moduleTitle=JAHA：左心室肥厚与接受经皮冠状动脉介入治疗的STEMI患者的梗死面积增大有关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e01a8e24227)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320740, encodeId=d8d31320e40a7, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=Heart：高龄老人ST段抬高型心肌梗死能否经皮冠状动脉介入治疗？, objectType=article, longId=79043, objectId=a72ee904393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a72ee904393, replyNumber=0, likeNumber=101, createdTime=2016-10-01, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a72ee904393, moduleTitle=Heart：高龄老人ST段抬高型心肌梗死能否经皮冠状动脉介入治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a72ee904393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320739, encodeId=ab611320e39ca, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, objectType=article, longId=78092, objectId=6164e8092e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6164e8092e7, replyNumber=0, likeNumber=38, createdTime=2016-09-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6164e8092e7, moduleTitle=2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6164e8092e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320738, encodeId=f3501320e3831, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=2012中国经皮冠状动脉介入治疗指南（简本）发布, objectType=article, longId=76169, objectId=62c7e6169ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62c7e6169ed, replyNumber=0, likeNumber=68, createdTime=2016-08-31, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62c7e6169ed, moduleTitle=2012中国经皮冠状动脉介入治疗指南（简本）发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62c7e6169ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320737, encodeId=68d21320e3791, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=2016中国经皮冠状动脉介入治疗指南发布, objectType=article, longId=76168, objectId=63fbe616821, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63fbe616821, replyNumber=0, likeNumber=84, createdTime=2016-08-31, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63fbe616821, moduleTitle=2016中国经皮冠状动脉介入治疗指南发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63fbe616821)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320736, encodeId=923e1320e36fc, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=2016经皮冠状动脉介入治疗术后运动康复专家共识发布, objectType=article, longId=75965, objectId=5f8fe5965ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f8fe5965ec, replyNumber=0, likeNumber=38, createdTime=2016-08-28, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f8fe5965ec, moduleTitle=2016经皮冠状动脉介入治疗术后运动康复专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f8fe5965ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320735, encodeId=fd531320e3595, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=JACC Cardiovasc Interv：经皮冠状动脉介入治疗时，桡动脉穿刺点优于股动脉, objectType=article, longId=73546, objectId=5232e354644, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5232e354644, replyNumber=0, likeNumber=60, createdTime=2016-07-25, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5232e354644, moduleTitle=JACC Cardiovasc Interv：经皮冠状动脉介入治疗时，桡动脉穿刺点优于股动脉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5232e354644)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320734, encodeId=41e41320e34c5, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=OCC 2016：落实全程康复理念，改善患者术后预期--《经皮冠状动脉介入治疗（PCI）术后运动康复专家共识》, objectType=article, longId=69422, objectId=456869422dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=456869422dc, replyNumber=0, likeNumber=76, createdTime=2016-05-30, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=456869422dc, moduleTitle=OCC 2016：落实全程康复理念，改善患者术后预期--《经皮冠状动脉介入治疗（PCI）术后运动康复专家共识》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=456869422dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320733, encodeId=e4411320e3356, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=解读|中国经皮冠状动脉介入治疗指南（2016）, objectType=article, longId=69315, objectId=72fa69315fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72fa69315fd, replyNumber=0, likeNumber=79, createdTime=2016-05-28, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72fa69315fd, moduleTitle=解读|中国经皮冠状动脉介入治疗指南（2016）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72fa69315fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320732, encodeId=0ef31320e328d, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=中国经皮冠状动脉介入治疗指南（2016）简介, objectType=article, longId=68009, objectId=bea76800982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bea76800982, replyNumber=0, likeNumber=82, createdTime=2016-05-13, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bea76800982, moduleTitle=中国经皮冠状动脉介入治疗指南（2016）简介, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bea76800982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1320731, encodeId=82c41320e31fb, content=<a href='/topic/show?id=cd29e838938' target=_blank style='color:#2F92EE;'>#经皮冠状动脉介入治疗#</a>, objectTitle=BMJ：患者对经皮冠状动脉介入治疗的获益过于乐观, objectType=article, longId=46646, objectId=5de746646a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5de746646a7, replyNumber=0, likeNumber=92, createdTime=2015-02-06, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5de746646a7, moduleTitle=BMJ：患者对经皮冠状动脉介入治疗的获益过于乐观, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5de746646a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

经皮冠状动脉介入治疗

2020-05-29

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Lancet：冠状动脉旁路移植术与经皮冠状动脉介入治疗对不同类型冠心病患者死亡率的影响

2018-02-25

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Circ-Cardiovasc Inte：经皮冠状动脉介入治疗后腹膜后出血！

2018-02-16

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Circ-Cardiovasc Inte：经皮冠状动脉介入治疗的终末期肾病患者抗凝治疗！

2018-02-09

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Heart：不同抗血小板治疗与经皮冠状动脉介入治疗死亡率之间的关系！

2018-02-05

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

HEART：慢性完全闭塞经皮冠状动脉介入治疗的预测因素！

2017-10-16

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Diabetic Med：糖尿病对慢性全身闭塞经皮冠状动脉介入治疗急性结局的影响

2017-07-08

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

CIRC J：血清白蛋白和C反应蛋白对经皮冠状动脉介入治疗患者的远期结局的作用

2017-04-28

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JAHA：左心室肥厚与接受经皮冠状动脉介入治疗的STEMI患者的梗死面积增大有关！

2017-01-12

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

Heart：高龄老人ST段抬高型心肌梗死能否经皮冠状动脉介入治疗？

2016-10-01

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

2016SIC共识——经皮冠状动脉介入治疗后双抗治疗更佳持续时间发布

2016-09-23

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

2012中国经皮冠状动脉介入治疗指南（简本）发布

2016-08-31

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

2016中国经皮冠状动脉介入治疗指南发布

2016-08-31

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

2016经皮冠状动脉介入治疗术后运动康复专家共识发布

2016-08-28

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

JACC Cardiovasc Interv：经皮冠状动脉介入治疗时，桡动脉穿刺点优于股动脉

2016-07-25

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

OCC 2016：落实全程康复理念，改善患者术后预期--《经皮冠状动脉介入治疗（PCI）术后运动康复专家共识》

2016-05-30

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

解读|中国经皮冠状动脉介入治疗指南（2016）

2016-05-28

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

中国经皮冠状动脉介入治疗指南（2016）简介

2016-05-13

aids213 (审核中...)

前往app查看评论内容

#经皮冠状动脉介入治疗#

BMJ：患者对经皮冠状动脉介入治疗的获益过于乐观

2015-02-06

科室
- - 订阅+
  - 更多科室
工具
服务